Operating income increased 9.8%
Operating income changed +9.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +9.8% from the comparable as-filed period.
Trade receivables changed -16.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -22.8% from the comparable as-filed period.
Inventory / revenue changed +711 basis points from the comparable as-filed period.
Free-cash-flow proxy changed +206.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash flow changed +208.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Capital expenditure changed -100.0% from the comparable as-filed period.
Cash & equivalents changed -19.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Research & development changed -8.0% from the comparable as-filed period.
Current ratio changed -15.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Total assets changed -6.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current assets changed +7.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital / assets changed +147 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Shares outstanding changed +1.3% from the comparable as-filed period. The change ranks at the 0th percentile of 7 prior comparable changes.
Working capital changed +2.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory changed +220.6% from the comparable as-filed period.
Stock-based compensation changed -23.2% from the comparable as-filed period.
Receivables / revenue changed +755 basis points from the comparable as-filed period.
Shares outstanding changed +18.5% from the comparable as-filed period. The change ranks at the 57th percentile of 7 prior comparable changes.
Research & development changed -11.8% from the comparable as-filed period.
Current liabilities changed +8.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Total assets changed -1.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory / revenue changed -56 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.